Levels of CD42–CD31 + EMPs were significantly increased over two-fold in diabetes patients with ACS when compared to healthy subjects (257.5 ± 35.58 vs. 105.7 ± 12.96; respectively, p < 0.01). This evidence concerns the gene PECAM1 and diabetes mellitus.